Fortress Biotech, Inc.

NASDAQ:FBIO

Biotechnology

Healthcare
$1.77 -1.79%

-$0.06 today

Market cap
$59.03M
Beta
1.23
P/E (TTM)
0.7
EPS (TTM)
$4.05
52W Low $1.70High $4.53

Volume 0.19M

Average 0.43M

Balance Sheet

Inspect the capital base behind the business.

Assets

$185.55M

FY 2025 · Annual

+28.7% YoY

Liabilities

$123.36M

FY 2025 · Annual

-15.4% YoY

Equity

$62.18M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents305.74M178.27M80.93M57.26M79.38M
Short-term Investments00000
Net Receivables23.79M28.35M15.39M10.4M29.94M
Inventory9.86M14.16M10.21M14.43M9.62M
Other Current Assets09.66M10.5M8.28M5.05M
Total Current Assets346.46M230.43M117.02M90.37M123.84M
Property, Plant & Equipment (Net)34.07M33.01M23.5M17.12M14.82M
Goodwill00000
Intangible Assets12.55M27.2M20.29M31.86M27.61M
Long-term Investments2.22M2.69M2.44M1.55M17.66M
Tax Assets(2.22M)(2.69M)000
Other Non-current Assets3.42M3.66M4.28M3.32M1.62M
Total Non-current Assets50.04M63.87M50.5M53.85M61.71M
Total Assets396.5M294.3M167.53M144.22M185.55M
Account Payables47.43M57.24M34.81M31.64M14.24M
Short-term Debt5.32M10.18M3M625K0
Tax Payables345K722K843K932K356K
Deferred Revenue2.61M728K000
Other Current Liabilities34.42M46.62M9.06M4.84M2.31M
Total Current Liabilities101.04M127.72M84.91M71.4M49.74M
Long-term Debt46.56M93.14M60.86M57.96M59.5M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.03M1.85M1.89M1.76M1.45M
Total Non-current Liabilities69.58M116.56M81.03M74.47M73.62M
Total Liabilities170.63M244.28M165.94M145.87M123.37M
Common Stock101K110K15K28K32K
Retained Earnings(547.46M)(634.23M)(694.87M)(740.87M)(734.05M)
Accumulated OCI00000
Other Stockholders Equity0(103K)000
Minority Interest117.2M8.3M(20.96M)(24.38M)12.31M
Total Equity225.88M50.03M1.59M(1.64M)62.18M
Total Debt74.98M127.34M84.66M75.96M74.3M
Net Debt(230.77M)(50.92M)3.73M18.7M(5.08M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$255.8M
Receivables$25.5M
Inventory$9.3M
Other Current$4.8M
Total Current Assets$295.5M
PP&E (Net)$14.2M
Intangible Assets$26.5M
Long-term Investments$19.9M
Other Non-current$740.0K
Total Non-current Assets$61.4M
Total Assets$356.9M

Analysis

Selected assets total $356.9M for Latest. The largest visible component is Cash & Equivalents at $255.8M, about 71.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
8-KCurrent reportOct 1, 2026
4Statement of changes in beneficial ownershipOct 1, 2026

How much cash does FBIO have?

Fortress Biotech, Inc. (FBIO) reported $79.38M in cash and equivalents in fiscal 2025.

How much debt does FBIO carry?

Fortress Biotech, Inc. (FBIO) reported $74.30M of total debt, with net debt of -$5.08M.